BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Chapter

Reset

Active filters

Chemical substance: Medroxyprogesterone acetate

Presentation	Product	Chemical substance	Chapter	Items dispensed
Medroxyprogesterone 10mg/5ml oral liquid 0803020H0AAARAR	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available
Medroxyprogesterone 200mg/5ml oral suspension 0803020H0AAAQAQ	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available
Medroxyprogesterone 20mg/5ml oral suspension 0803020H0AAAPAP	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available
Medroxyprogesterone 250mg tablets 0803020H0AAAEAE	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available
Medroxyprogesterone 400mg/5ml oral liquid 0803020H0AAAKAK	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available
Medroxyprogesterone 500mg tablets 0803020H0AAAGAG	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available
Medroxyprogesterone 500mg/2.5ml inj vials 0803020H0AAABAB	Medroxyprogest acetate (Cancer)	Medroxyprogesterone acetate	Malignant Disease and Immunosuppression	No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.